You Need to Be Mushroom-Maxxing

I'm going to make a claim that sounds absurd, and then I'm going to back it up.

There is a single food that reduces your risk of depression by roughly 25%, lowers your cancer risk, feeds your brain a compound that literally nothing else on the planet can produce, and yet most people eat it about as often as they clean behind the sofa.

It's not a berry. It's not kale. It's not whatever high-antioxidant powder some bloke on Instagram is flogging this week.

It's mushrooms.

Before you click away thinking this is some kind of wellness fluff piece - don’t. Because the science here is genuinely remarkable, and the implications go far beyond what you'd expect from something you can buy for pocket change at your local supermarket.

You've heard of antioxidants. You can probably name a few. You've almost certainly never heard of ergothioneine.

Ergothioneine is an amino acid, and here's what makes it extraordinary: your body evolved a dedicated transporter protein (a specific cellular doorway) solely to absorb it. Your cells do not do this for vitamin C. They don't do it for resveratrol. They don't do it for any of the molecules the supplement industry has spent billions convincing you to care about. But they do it for ergothioneine.

The catch? Your body cannot make it. And the only meaningful dietary source is mushrooms.

Now, where does ergothioneine accumulate once it's inside you? In your highest-stress tissues like your brain, your eyes, your liver, and your bone marrow. The organs doing the hardest work get the most protection. And as you age, your levels drop. Countries where mushroom consumption is highest show consistently lower rates of neurodegenerative disease. Correlation isn't causation, obviously, but at some point the correlations start stacking up to a height that's difficult to ignore.

A meta-analysis spanning over 600,000 participants found that regular mushroom consumption was associated with significantly lower risk of cancer, depression, and all-cause mortality. The depression finding - a roughly 25% reduced risk - came from a Penn State study that controlled for the usual confounders. This isn't observational hand-waving. Something real is going on.

Everyone's banging on about fibre for gut health, and rightly so. But most people's mental model of "fibre" starts and ends with porridge and chickpeas. Mushrooms are a fibre source that almost nobody optimises for, and the type of fibre they carry (beta-glucans) do something rather specific.

Beta-glucans are prebiotic. They feed the particular gut bacteria that produce butyrate, a short-chain fatty acid that is arguably the single most important molecule for keeping your intestinal lining intact. Butyrate keeps the barrier tight. When butyrate drops, you get permeability. When you get permeability, you get systemic inflammation. And when you get systemic inflammation, you get, well, you get the modern disease landscape. Heart disease, autoimmunity, metabolic dysfunction, depression. The whole sorry catalogue.

Mushrooms are also absurdly low in calories, high in water content, and surprisingly filling. Research on appetite regulation has shown that swapping meat for mushrooms in meals produces the same reported satiety with significantly fewer calories consumed. The short-chain fatty acids produced from mushroom beta-glucans also increase GLP-1 naturally - the same pathway that those eye-wateringly popular weight-loss injections target.

So if you care about body composition, mushrooms are one of the most underused tools available. And they cost about forty pence a serving.

Beyond your standard button and cremini, there's a class of mushrooms that have been used in traditional medicine for centuries and are now being validated by proper science. Each one does something surprisingly specific.

Lion's Mane stimulates the production of Nerve Growth Factor, a protein that promotes the growth and maintenance of neurons. Published research shows that compounds in Lion's Mane (hericenones and erinacines) cross the blood-brain barrier and encourage neurogenesis. Your brain can grow new cells. This mushroom appears to help it do so.

Cordyceps contains a nucleoside analogue called cordycepin that mimics adenosine, the molecule at the heart of your cellular energy system (it's the "A" in ATP). Research shows effects on oxygen utilisation, metabolic efficiency, and blood sugar regulation. There's a reason it keeps appearing in sports performance and metabolic health literature.

Reishi has been called the "mushroom of immortality" in Chinese medicine for two thousand years, which sounds like marketing, except modern research backs it up. Its triterpenes and polysaccharides modulate the immune system rather than simply "boosting" it. It calms overactive immune responses while supporting underactive ones. This bidirectional activity is rare in nature and is why reishi is also studied in the context of stress adaptation and sleep quality.

Turkey Tail is one of the most researched mushrooms in oncology. Its polysaccharide-K (PSK) is an approved adjunct cancer therapy in Japan. The mechanism is immune modulation - specifically, activation of natural killer cells and T-cells. Your immune system is your first line of defence against aberrant cell growth, and Turkey Tail appears to sharpen it.

Chaga carries one of the highest antioxidant scores ever recorded in a food and has demonstrated anti-inflammatory properties in preliminary research. It's traditionally drunk as a tea and is being studied for its effects on oxidative stress and gut health.

Each of these does something different. That's the point. This isn't a single-mechanism story. This is an entire kingdom of organisms offering a health toolkit we're only beginning to map.

Here's where I want to go beyond nutrition for a moment, because fungi genuinely altered how I think about systems.

Fungi are not plants. They're not animals. They're their own kingdom, and they operate on principles that challenge most of our default assumptions about how living things work.

Consider the mycelial network. A single fungal organism can span thousands of acres underground, connecting trees across a forest, redistributing nutrients from areas of surplus to areas of need. Dying trees send their carbon through fungal networks to neighbouring trees. Older trees subsidise younger ones. The forest isn't a collection of individuals competing for sunlight. It's a wildly complex, competitive and collaborative network - much like a city or an economy - and fungi are the infrastructure.

This isn't metaphor. It's measurable biology. And it offers an accurate model for thinking about systems, whether biological, economic, social, technological.

Mushrooms are also nature's great decomposers. They break down dead matter and convert it into bioavailable nutrients. Without fungi, dead plant matter would simply pile up. The carbon cycle as we know it would collapse. Forests would not regenerate. Life, as currently configured, would grind to a halt.

And then there's mycoremediation - aka using fungi to clean contaminated environments. Certain species can break down petroleum products, filter heavy metals from water, and decompose plastics. Paul Stamets demonstrated oyster mushrooms degrading diesel-soaked soil into a functioning garden within weeks. The potential for environmental restoration is enormous and still wildly underexplored.

The lesson fungi offer is one of decentralisation and regeneration. No central command. No hierarchy. Just a network that senses conditions, adapts, and distributes resources based on need. If you're interested in building resilient systems of any kind, fungi are possibly the best teacher on the planet.

And then there's the molecule that nobody in polite society wanted to discuss for fifty years.

Psilocybin, the psychoactive compound in "magic mushrooms", has gone from Schedule I pariah to FDA breakthrough therapy designation in under a decade. The clinical results are, frankly, difficult to overstate.

Johns Hopkins, Imperial College London, NYU, and others have published trial data showing that one or two guided psilocybin sessions can produce dramatic, lasting reductions in treatment-resistant depression, end-of-life anxiety, and addiction. Single sessions producing effects that persist for months, sometimes years. No daily pill. No prescription refills. No toxic side effects. It's a fundamentally different treatment paradigm, and it's making the existing model look rather antiquated.

The mechanism appears to involve a temporary increase in neural connectivity. Your brain's default mode network (the part responsible for your sense of self, your habitual thought loops, your ego) quiets down, and regions that don't normally communicate begin talking to each other. The rigid patterns that characterise depression, anxiety, and addiction are temporarily dissolved, and the brain gets a window to rewire.

But here's where it gets truly interesting. A study published in npj Aging in 2025 provided the first experimental evidence that psilocybin may be a potent anti-ageing agent. Researchers at Emory University and Baylor College of Medicine treated human cells with psilocin (psilocybin's active metabolite) and found it extended cellular lifespan by 29% at a standard dose and 57% at a higher dose.

The treated cells showed delayed onset of senescence, preserved telomere length, reduced oxidative stress, and increased expression of SIRT1, a protein critically involved in regulating cellular ageing and longevity.

Then they tested it in living animals. Aged mice received monthly psilocybin treatments for ten months. 80% of the treated mice survived, compared to 50% in the control group. The treated mice also showed visible improvements in fur quality and hair regrowth. A statistically significant survival advantage from a molecule we were told for decades had no medical value whatsoever.

The implications are staggering. We already knew psilocybin could rewire the brain. Now there's evidence it may slow the biological clock at a cellular level. The researchers describe it as a potentially "disruptive" geroprotective agent - which, in the restrained language of academic publishing, is about as excited as scientists get.

Australia has already legalised psilocybin therapy. Several US states and cities have decriminalised or are building therapeutic frameworks. The regulatory landscape is shifting fast, and the research pipeline is accelerating.

Start simple. Eat more mushrooms. I mean it. Aim for at least one serving a day. Rotate through culinary varieties - shiitake, maitake, oyster, cremini - to get the broadest spectrum of beta-glucans, ergothioneine, and micronutrients. It doesn't need to be complicated. Throw them in an omelette. Chuck them in a stir-fry. Roast them with garlic and eat them straight off the tray. I won't judge.

If you want to go deeper, explore functional mushroom extracts. Look for products that use fruiting body (not mycelium grown on grain) and that are transparent about beta-glucan content. The difference matters. If you’re in the UK, check out my brand Mushies. If you;re in the US, I’m a big fan of SuperMush.

And beyond the practical, study fungi. Read Merlin Sheldrake's Entangled Life. Watch Paul Stamets' talks. Pay attention to the mycoremediation research. Let the way fungi operate genuinely reshape how you think about networks, resilience, and regeneration.

The mushroom kingdom has been doing more with less, for longer, than any other complex life on Earth. It built the soil that allowed plants to colonise land. It connects forests. It decomposes the dead so new life can emerge. It produces molecules that grow neurons, regulate immune systems, and may hold keys to the mental and physical health crisis of our time.

This isn't a trend. It's a technology that's been running for over a billion years.

Time to start mushroom-maxxing.